The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.
Patients with comorbid hypertension and type 2 diabetes are common, have a greatly increased risk of premature cardiovascular and renal morbidity and mortality, and are likely to increase substantially in number over the next 10-15 years. We suggest the need for more aggressive management strategies for these patients, regardless of their baseline blood pressure, including the early use of combination therapy with blockers of the renin-angiotensin system.
Rydén
Lars
L
Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden. lars.ryden@ki.se
Waeber
Bernard
B
Ruilope
Luis M
LM
Mancia
Giuseppe
G
Volpe
Massimo
M
Holzgreve
Heinrich
H
Mogensen
Carl Erik
CE
Laurent
Stephane
S
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D048909:Diabetes Complications / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology; D019468:Disease Management; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D012084:Renin-Angiotensin System / Q000187:drug effects; D016896:Treatment Outcome
D000959:Antihypertensive Agents